Heider, K., Kiefer, K., Zenz, T., Volden, M., Stilgenbauer, S., Ostermann, E., . . . Borges, E. (2011). A novel Fc-engineered monoclonal antibody to CD37 with enhanced ADCC and high proapoptotic activity for treatment of B-cell malignancies. American Society of Hematology.
シカゴスタイル引用形Heider, Karl-Heinz, et al. A Novel Fc-engineered Monoclonal Antibody to CD37 With Enhanced ADCC and High Proapoptotic Activity for Treatment of B-cell Malignancies. American Society of Hematology, 2011.
MLA引用形式Heider, Karl-Heinz, et al. A Novel Fc-engineered Monoclonal Antibody to CD37 With Enhanced ADCC and High Proapoptotic Activity for Treatment of B-cell Malignancies. American Society of Hematology, 2011.
警告: この引用は必ずしも正確ではありません.